Drug application
BIPHETAMINE 20 (AMPHETAMINE RESIN COMPLEX, DEXTROAMPHETAMINE RESIN COMPLEX)
Drugs@FDA NDA 010093 · UCB INC
Key facts
| Drug name | BIPHETAMINE 20 |
|---|---|
| Active ingredients | AMPHETAMINE RESIN COMPLEX, DEXTROAMPHETAMINE RESIN COMPLEX |
| Application type | NDA |
| Application number | 010093 |
| Company | UCB INC |
| Dosage forms | CAPSULE, EXTENDED RELEASE, ORAL |
| Strength | EQ 10MG BASE;EQ 10MG BASE |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 2 - New Active Ingredient |
| Latest submission status date | Sep 9, 1955 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.